Drug details
Zenzedi (dextroamphetamine sulfate tablets, usp)
type of Stimulants, ADHD Agents
Zenzedi (dextroamphetamine sulfate tablets) is an amphetamine for the treatment of narcolepsy. Zenzedi is also indicated as a treatment for attention deficit hyperactivity disorder (ADHD) in pediatric patients ages 3 to 16 years as an integral part of a total treatment program for ADHD that may include counseling or other therapies.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- fever,
- lightheadedness,
- chest pain,
- diarrhea
- sweating,
- agitation,
- shivering,
- vomiting, and
- seizures,
- hostility,
- aggression,
- trouble breathing,
- hallucinations,
- paranoia,
- fast heart rate,
- loss of coordination,
- muscle stiffness,
- skin color changes (pale, red, or blue appearance) in your fingers or toes,
- muscle twitches,
- changes in your vision,
- new behavior problems,
- cold feeling in your fingers or toes,
- numbness and pain in your fingers or toes,
- unexplained wounds on your fingers or toes,
The following drugs are related to Zenzedi, either as a replacement or used together:
- Adderall (amphetamine, dextroamphetamine mixed salts)
- Adderall XR (amphetamine, dextroamphetamine mixed salts)
- Adhansia XR (methylphenidate hydrochloride extended-release capsules)
- Strattera (atomoxetine hcl)
- Celexa (citalopram hydrobromide)
- Concerta (methylphenidate extended-release tablets)
- Xelstrym (dextroamphetamine)
- Lexapro (escitalopram oxalate)
- Vyvanse (lisdexamfetamine dimesylate)
- Methylin Chewable Tablets (methylphenidate hcl chewable tablets)
- Methylin Oral Solution (methylphenidate hcl oral solution 5 mg/5 ml and 10 mg/5 ml)
- Ritalin (methylphenidate hcl)
- Quillivant XR (methylphenidate hydrochloride extended release oral suspension, cii)
- Ritalin LA (methylphenidate hydrochloride extended-release capsules)
- Zoloft (sertraline hcl)
- Sunosi (solriamfetol tablets)